Avelumab

ATC L01FF04 · 11 markets · 15 records

Avelumab 11 markets · 15 records Forms

AU 3 records · 3 strengths

  • 200 mg/10 mLinjectionBAVENCIO also in GB·SG
  • 20 mg/mLinjectionBAVENCIO avelumab (rch) 200 mg/10 mL concentrated solution for intravenous infusion vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

ES 3 records · 1 strengths

US 1 records · 1 strengths

GB 1 records · 1 strengths

  • 200 mg/10 mLinjectionBavencio 200mg/10ml concentrate for solution for infusion vials also in AU·SG

CA 1 records · 1 strengths

SG 1 records · 1 strengths

TW 1 records · 1 strengths

HK 1 records · 1 strengths

    1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
    With a brand name Con nombre comercial 有商品名 有商品名BAVENCIO CONCENTRATE FOR SOLUTION FOR INFUSION 200MG/10ML ×1

    Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

      FR 1 records · 1 strengths

      • 20 mg/1 mLinjectionBAVENCIO 20 mg/mL, solution à diluer pour perfusion also in ES

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.